CLINICAL_TRIALS
trial_result
· 2021-01-12
Clinical Trial Update: Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata [Phase 2]
Summary
Phase 2 trial update evaluating combined Restylane and Triamcinolone Acetonide injections for alopecia areata; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2021-01-12